Sanofi India Limited (BOM:500674)
3,282.85
-96.55 (-2.86%)
At close: Nov 6, 2026
Sanofi India Market Cap
Sanofi India has a market cap or net worth of 75.61 billion as of November 6, 2026. It is the 11,208th most valuable company in the world and the 683rd biggest in India. Its market cap has decreased by 30.93% in one year.
Market Cap
75.61B
Enterprise Value
72.07B
Revenue
18.22B
Global Rank
Country Rank
#683 India
PE Ratio
20.74
ChartMarket Cap Chart
Since March 19, 2001, Sanofi India's market cap has increased from 11.29B to 75.61B, an increase of 569.97%. That is a compound annual growth rate of 7.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 75.61B | -19.77% |
| Dec 31, 2025 | 94.23B | -33.15% |
| Dec 31, 2024 | 140.97B | -24.12% |
| Dec 29, 2023 | 185.79B | 37.91% |
| Dec 30, 2022 | 134.72B | -25.89% |
| Dec 31, 2021 | 181.78B | -5.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca Pharma India | 159.13B |
| Jubilant Pharmova | 148.80B |
| Viyash Scientific | 100.87B |
| Procter & Gamble Health | 94.75B |
| Bliss GVS Pharma | 66.52B |
| FDC Limited | 63.68B |
| Morepen Laboratories | 54.93B |
| Evonile Pharma | 42.88B |